Enzo Biochem, Inc. Overview
Pro stress-test →Enzo Biochem has operated as a life sciences company for over 45 years, with its primary business conducted through Enzo Life Sciences, focusing on labeling and detection technologies from DNA to whole cell analysis including antibodies, genomic probes, assays, biochemicals, and proteins. The company's proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry.
Strategic Profile
Pro stress-test →The company monetizes its technology primarily via sales through its global distribution network and licensing. As of August 20, 2025, Enzo Biochem was taken private by Battery Ventures. The company serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers.
Competitive Landscape
Pro stress-test →Enzo operates in the research reagents and life sciences tools market alongside companies like Thermo Fisher Scientific, Bio-Rad Laboratories, and Abcam. The company's niche focus on labeling and detection technologies differentiates it, though it competes against larger, better-capitalized rivals with broader product portfolios and global distribution capabilities.
Industry Context
Enzo Biochem, Inc. operates in Life Sciences Tools & Reagents / Diagnostics & Research.
Key facts
Founded: 1976 · Headquarters: Farmingdale, New York, US · Employees: 136 · Revenue: $27.47M · Market cap: $36.59M